Bunge soybean oil heart health claim approved by US FDA

3108501e-9fca-4acf-b363-32b2d795bdccarticleimage.jpg

01 Aug 2017 --- The US Food and Drug Administration (FDA) has approved Bunge North America’s petition for a qualified health claim linking soybean oil consumption to reduced risk of heart disease. Soybean oil is the US’ most commonly used ingredient and top dietary source of polyunsaturated fats.

Bunge reports that it independently filed a petition with the FDA that included a summary of recent major clinical studies showing the potential benefits of soybean oil to heart health based on its demonstrated positive effect on cholesterol levels and its high concentration of polyunsaturated omega 6 and omega 3 fatty acids versus other oils and fats. 

Click to EnlargeCompanies can now communicate that soybean oil may reduce heart disease risk and lower LDL-cholesterol when replacing saturated fat and not increasing calories.

“Bunge is committed to enhancing the value of America’s most accessible food oil,” says Dr. Mark Stavro, Senior Director of Marketing, Bunge North America. “The FDA’s decision provides opportunities for food companies to develop more heart healthy products, for consumers looking to improve their heart health and for soybean farmers who thrive when demand for their crop increases.”

The US is the world’s leading soybean producer, accounting for 33 percent of global production. Bunge is a leading soybean oil producer globally and works closely with soybean farmers in the US and other regions to turn their harvests into oils that are foundational part of many people’s diet.

“We take great pride in the trusted relationships we have with our farmer-customers and work hard to develop new markets for their crops,” says Timothy Gallagher, Executive Vice President, oilseed value chain, Bunge North America. “By promoting soybean oil’s heart health benefits, we are helping to drive demand for a high quality product that can benefit the full soybean value chain.”

Related Articles

Nutrition & Health News

Drink your vitamins: SternVitamin launches micronutrient premix for beverages 

19 Feb 2018 --- A healthy lifestyle is essential to all age groups, and nutrition plays a major role alongside various other components. SternVitamin is now offering beverage manufacturers a novel way to address the topic of health with a new micronutrient premix for healthy bones and heart. SternVitamin notes that the mix picks up on one of the top trends in the beverage market – water-based enriched products. The vegan premix contains vitamins B1, B12, C, K2 and D3. Organic agave syrup powder gives it a slight sweetness, while natural flavors give the drink a “dark berry” taste. It dissolves clear in water and leaves no turbidity. 

Nutrition & Health News

“Unhelpful”: EU regulatory framework fuels nutrition industry dissatisfaction 

16 Feb 2018 --- A survey reveals that one-third of all nutrition industry professionals believe that the current EU framework for achieving a health claim on new products is stunting innovation because it’s complicated, expensive, long-winded and has several “gray areas.” And “regulation frustration” is a strong feeling running through the industry with many more professionals now believing the current EU regulatory environment is “unhelpful” – a 25 percent hike compared with statistics from the beginning of 2017. Experts are attributing this sharp rise in dissatisfaction to the EU’s tough stance on health claims and the current regulatory deadlock on botanicals.

Business News

AI and personalized nutrition: Nestlé and Nuritas partner on bioactive peptide development

09 Feb 2018 --- Nestlé and biotech company Nuritas have entered into a collaboration aiming to uncover bioactive peptide networks within “specific target areas of significant value.” The precise areas of investigation are not yet being shared, with Nuritas Commercial Manager Neil Foster telling NutritionInsight that these details and the expected launch date are “at this early stage understandably confidential.” As part of the collaboration, Nuritas is to deploy its novel technology platform, which uses Artificial Intelligence and DNA analysis to predict, unlock and validate highly efficacious peptides, exclusively from natural food sources. Nestlé will use their considerable scientific know-how and applications expertise to validate the efficacy of these discoveries within the target applications.

Nutrition & Health News

L-Carnitine – "Unquestionable" room for market growth: Lonza

08 Feb 2018 --- From facilitating the recovery process in the sports nutrition sector to improving energy metabolism in healthy aging products, L-Carnitine has proven itself a versatile ingredient with the potential to be applied in myriad applications. “Sports nutrition, weight management, all these areas are still growing. There is no question that there is a lot of room for L-Carnitine’s development. We see a lot of demand coming from Asia and Africa for infant food applications. The other big market is for sure energy drinks,” Marco Gossen, Business Development Manager at Lonza, explains during a NutritionInsight webinar last week, looking at product development and untapped opportunities for L-Carnitine.

Nutrition & Health News

Bioiberica: Convenience in formulation driving innovation in joint health

06 Feb 2018 --- The world’s older population continues to grow at an astounding rate. According to a report by the US’ Census Bureau, nearly 17 percent of the world’s population will be aged 65 and over by 2050, up from the current 8 percent. This aging of the population is reflected in a rising interest in age-related health aspects such as bone and joint health. Unsurprisingly maybe, mobility has also become a key area of focus as the loss of physical mobility that so often accompanies aging is the number one reason why many elderly people end up in nursing homes.

More Articles
URL : http://www.nutritioninsight.com:80/news/bunge-soybean-oil-heart-health-claim-approved-by-us-fda.html